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ABSTRACT A 2-year longitudinal microbiome study of 22 patients who underwent colectomy with an ileal pouch anal anasto-
mosis detected significant increases in distinct populations of Bacteroides during 9 of 11 patient visits that coincided with in-
flammation (pouchitis). Oligotyping andmetagenomic short-read annotation identified Bacteroides populations that occurred
in early samples, bloomed during inflammation, and reappeared after antibiotic treatment. Targeted cultivation of Bacteroides
isolates from the same individual at multiple time points and from several patients detected subtle genomic changes, including
the identification of rapidly evolving genomic elements that differentiate isogenic strains of Bacteroides fragilis from the mucosa
versus lumen. Each patient harbored Bacteroides spp. that are closely related to commonly occurring clinical isolates, including
Bacteroides ovatus, B. thetaiotaomicron, B. vulgatus, and B. fragilis, which contained unique loci in different patients for syn-
thesis of capsular polysaccharides. The presence of unique Bacteroides capsular polysaccharide loci within different hosts and
between the lumen andmucosa may represent adaptations to stimulate, suppress, and evade host-specific immune responses at
different microsites of the ileal pouch.
IMPORTANCE This longitudinal study provides an opportunity to describe shifts in the microbiomes of individual patients who
suffer from ulcerative colitis (UC) prior to and following inflammation. Pouchitis serves as a model for UC with a predictable
incidence of disease onset and enables prospective longitudinal investigations of UC etiology prior to inflammation. Because of
insufficient criteria for predicting which patients will develop UC or pouchitis, the interpretation of cross-sectional study de-
signs suffers from lack of information about the microbiome structure and host gene expression patterns that directly correlate
with the onset of disease. Our unique longitudinal study design allows each patient to serve as their own control, providing in-
formation about the state of the microbiome and host prior to and during the course of disease. Of significance to the broader
community, this study identifies microbial strains that may have genetic elements that trigger the onset of disease in susceptible
hosts.
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Cross-sectional studies have described dysbiosis (1, 2) and alarge number of host genes and single nucleotide polymor-
phisms (3, 4) associated with ulcerative colitis (UC), one of the
inflammatory bowel diseases (IBD) that cause chronic inflamma-
tion of the colon. Because clinicians lack criteria for predicting the
onset of UC, cross-sectional studies that compare UC patients
with individuals presumed to be healthy cannot unambiguously
attribute shifts in microbial communities or altered host gene ex-
pression patterns to initial inflammation events. Large interindi-
vidual differences in gut microbiota will confound attempts to
identify meaningful associations between shifts in the microbial
community and onset of disease. In contrast, longitudinal studies
of host gene expression and microbiome communities for indi-
vidual patients prior to and after the onset of UC minimizes the
influence of confounding factors that obscure cause-effect rela-
tionships.
Patients withmedically refractory UC often choose to undergo
surgical intervention to achieve cure and continence, which in-
volves a colectomy with an ileal pouch anal anastomosis (IPAA).
The ileal pouch functions as a new reservoir to store stool and
undergoes physiologic changes to become more “colon-like”
within the first 4 months, including colonic epithelial function
and a microbial composition similar to that residing in the colon
(5, 6). Although the ileal tissue is initially normal, nearly half of the
patients develop inflammation of the pouch (pouchitis), which
exhibits histologic and endoscopic features similar to UC (7). The
similarities between pouchitis and UC coupled with the predict-
able incidence of pouchitis enables prospective longitudinal in-
vestigations of UC etiology prior to inflammation.
Cross-sectional studies of pouchitis patients show that the bi-
opsy site and initial inflammation covary with changes in host
transcripts, whereas shifts in the pouch microbial community de-
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tected bymarker gene analyses correlate onlywith antibiotic treat-
ment (8). Beyond the inherent limitation of cross-sectional stud-
ies that do not include samples from the same patient before and
after onset of inflammation, marker gene analyses that focus on
rRNA gene targets might lack resolution required for detecting
subtle shifts in relative abundance of pathobionts and naturally
occurring host-associated microbes with nearly identical ge-
nomes. In contrast to large cross-sectional studies, marker gene
and shotgun metagenomic analyses in longitudinal studies pro-
vide a means to account for pouch microbiome differences be-
tween the healthy and inflamed pouch within an individual pa-
tient. The assembly of shotgun metagenomic reads into contigs
and assembled genomes have the potential to report differences in
rapidly evolving genomic regions of closely related organisms.
Such differences might represent horizontal gene transfers be-
tween Bacteroides, including genes that specify capsular polysac-
charide (CPS) biosynthesis (9), which can either stimulate or sup-
press an immune response (10–13), and conjugative transposons
that mobilize toxin genes (14).
We used a combination of 16S rRNA marker genes, shotgun
metagenomics, cultivation, and assembly-basedmetagenomics to
survey the gut microbial communities over a 2-year period after
patients had undergone IPAA. Themarker gene and shotgunmet-
agenomic short reads reported changes in the relative abundance
of potential pathobionts in response to inflammation and antibi-
otic stress throughout the course of disease for individual patients.
The combination of cultivation, assembly-based metagenomics,
and read mapping to cultivar genomes detected subtle genomic
changes mediated by putative horizontal gene transfer events be-
fore, during, and after inflammation events within the IPAA
pouches of individual patients (15).
RESULTS
Patient sampling. Based upon the pouch disease activity index, 9
patients developed pouchitis at least once during the 2-year study
period (p_patients), 10 patients never developed pouch inflam-
mation (n_patients), and 3 patients (p-500, p-502, and p-215)
developed pouchitis after completion of the study (see Table S1 in
the supplemental material). This 2-year longitudinal study in-
cluded 96 luminal content samples acquired at different time
points after functionalization of the ileal pouch (Fig. 1) from IBD
patients during visits where they exhibited inflammation (in-
flamed visits) (I samples), during visits where they did not exhibit
inflammation (visits without inflammation) (W samples), and
approximately 30 days following antibiotic treatment prescribed
for pouchitis (A samples). Thirty-nine of the luminal samples
came from surgically created pouches that never became inflamed
throughout the duration of the study (N samples), and a brush
sampling procedure recoveredmicrobes acquired from threemu-
cosal samples (GG sampling site) during periods of inflammation
after pouch functionalization.
Marker gene analysis. Amplicon sequencing from patient
samples recovered an average of 57,682 v4v5 rRNA marker gene
sequences from each of 92 samples. Sequences that GAST (Global
Alignment for Sequence Taxonomy) analyses (16) resolved to
Bacteroides ranged from 20 to 96% relative abundance during 8 of
11 periods of inflammation (see Fig. S1 and S2 in the supplemental
material). Other genera and families (taxa) that commonly occur
at relatively high abundance in the human gut, e.g., Clostridium,
Enterobacteriaceae, and Streptococcus, represented relatively low-
abundance taxa in samples from inflamed visits. The linear
mixed-effects models (LMMs) estimated an average increase in
the relative abundance of Bacteroides of 27% (97.5% confidence
interval [97.5%CI], 10.4% to 43.4%) during inflammation versus
all other samples (Benjamini-Hochberg [BH]-adjusted P value of
0.073). The Cetobacterium model estimate of 4.1% (97.5% CI,
0.057% to 14.1%) increase during inflammationwas the second
highest among all taxa. The top three taxa that negatively corre-
lated with inflammation included Lachnospiraceae, Streptococcus,
and Enterobacteriaceae with percent decrease of 8.4, 7.9, and 6.2,
respectively (Table S2). Microbial communities significantly dif-
fered (i) among patients (all samples from one patient versus all
samples from another patient), (ii) between p_patients and n_pa-
tients, and (iii) among pouch conditions at the time of sampling,
and these three differences account for 43%, 3%, and 3% of the
total variation, respectively (Table 1). The analysis of variance
(ANOVA) of the relative abundance of Bacteroides reported sig-
nificant differences between the W and I samples (P 0.02) (Ta-
ble 3; Fig. S2) but no significant differences in pairwise compari-
sons of samples from all other states.
Minimum entropy decomposition (MED) analysis, which
employs Shannon entropy calculations to differentiate marker
gene sequences that may differ by only a single nucleotide (17),
resolved 312 distinct oligotypes (18) and described beta diver-
sity that according to permutational multivariate analysis of
variance (PERMANOVA) tests are nearly identical to the analysis
of GAST genus-level taxon assignments. Community composi-
tion (Fig. 2) significantly differed among patients, among N, I, W,
and A samples and between p_patients and n_patients (Table 1).
A significant shift in microbial communities of pouchitis patients
FIG 1 Longitudinal sampling of pouchitis and nonpouchitis patients. Sam-
ples from p_patients (patients who experienced inflamed ileal pouches at least
once during the 2-year study) were collected during periods of inflammation
(inflamed pouch), in the absence of inflammation, and 30 days after adminis-
tration of antibiotics (post antibiotic). Samples were also collected from n_pa-
tients who never developed inflammation during the study period (non-
pouchitis).
Vineis et al.















involved expansion ofBacteroides fromamean relative abundance
of 20% prior to inflammation to 50% in I samples (see Fig. S2 in
the supplemental material). For the entire pouchitis patient co-
hort, oligotypes identified rRNA sequences with perfect matches
to the NCBI RefSeq RNA database for Bacteroides fragilis (1 oligo-
type), B. ovatus (2 oligotypes) and B. vulgatus (3 oligotypes) dur-
ing 9 of the 11 periods of inflammation (Fig. 2) with a minimum,
maximum, and average percent relative abundance of 0.44, 73,
and 35.7, respectively (Table S3). A single B. fragilis oligotype
(2373) represented the dominant organism in 3 of the 11 samples
taken during inflammation (Fig. 2), and LMMs predicted the
highest increase in relative abundance of any oligotype (10.9%;
97.5% CI, 2.1 to 19.9) (BH-adjusted P value of 0.232) during
inflammation (Table S2). Some patients exhibited increases for
more than one oligotype that resolved to the same species. For
example, the p-208 I sample contained abundant B. ovatus and
B. vulgatus, each represented by two distinct oligotypes (Fig. 2).
LMMs predicted positive inflammation coefficients for several
B. vulgatus and B. ovatus oligotypes (Table S2). In three patients
(p-213, p-204, and p-207), the B. fragilis oligotype 2373 repre-
sented the most abundant population in the microbiome during
inflammation and was present more than 300 days prior to the
onset of inflammation. The same oligotype occurred in relatively
high abundance in patients who did not develop inflammation
(p-212 and p-210). LMMs predicted positive correlation between
several low-abundance taxa with inflammation. Oligotype 1114,
with exact sequence similarity to B. faecis and B. thetaiotaomicron,
increased, on average, 2.3% during inflammation. LMMs esti-
mated negative correlations between inflammation and oligo-
types with high sequence similarity to Streptococcus and Lachno-
spiraceae, but decreases never exceeded 3.5% (Table S2).
Metagenomic short-read functional potential and taxon-
omy. Shotgun metagenomic sequencing, quality filtering, and
merging of paired-end reads from 170-bp insert libraries for 99
samples (96 luminal samples plus 3 mucosal samples) yielded
555 Gb (~33 million reads/sample). MG-RAST (metagenomic
rapid annotation ofmicrobial genomes using subsystems technol-
ogy) (19) annotation of all samples identified 13,325 functions.
However, the functional potential of microbial communities did
not differ between n_patients and p_patients or among W, I, A,
and N samples (see Fig. S3 in the supplemental material). Func-
tional potential differed significantly among patients and ex-
plained 29% of the variation (P  0.001). In agreement with the
16S rRNA estimates, the mean relative abundance of Bacteroides,
according to taxonomic assignment of short reads to theM5nr (nr
stands for nonredundant) protein database, differed significantly
in I samples compared to W samples (Table 3; Fig. S2).
Assembly and temporal changes in metagenome assembled
genomes. Each metagenome assembly included reads from all
longitudinal samples for each patient. Using assembled contigs of
5 kbp, anvi’o (20) displayed 63 Bacteroides “metagenome as-
sembled genomes” (MAGs) with an average size, completion, and
redundancy of 4.18 Mbp, 58.8%, and 4.6%, respectively. These
MAGs describe 12 B. fragilis, 4 B. ovatus, 12 B. thetaiotaomicron,
and 11 B. vulgatus draft genomes. One or more of these genomes
were present in 9 of the 11 samples collected during inflammation
(Fig. 3), but for any one patient, only a single B. fragilis MAG
assembled in the metagenome of pooled luminal (M) samples.
Based upon mapping short reads back to the assembly, the abun-
dance of the Bacteroides group (B. fragilis, B. ovatus, B. vulgatus,
and B. thetaiotaomicron) was significantly greater in I samples
than in N and W samples (Table 3; see also Fig. S2 in the supple-
mental material). We isolated an additional 354 MAGs longer
than 1.5 Mbp with no more than 10% single-copy gene redun-
dancy (Table S4).
Functional analyses of MAGs. Annotation of the 63 Bacte-
roides MAGs produced a set of 7,011 distinct functions. Each ge-
nome contained an average of 3,468 genes, and the identified
functions ofBacteroidesMAGs did not differ significantly between
n_patients and p_patients (Table 2; see also Fig. S4 in the supple-
mentalmaterial). The species-level classification explained 54%of
the variation in functional assignmentswithMAGs that form tight
clusters differing at multiple loci. For example, the B. fragilis
p207-33 (patient 207 sample taken 33 days after pouch activation)
and B. fragilis p212-31MAGs are 93% and 97% complete, respec-
tively (Table S4), and each contains ~190 unique gene features.
The high relative abundance of clinically relevant Bacteroides
during inflammation motivated an investigation of the genes
TABLE 2 Functional diversity of Bacteroides MAGsa
Comparison R2 P value Dispe
Patient groupb 0.01 0.87 0.607
Speciesc 0.54 0.001 0.001
Patientd 0.21 1 0.001
a Summary of the results of ADONIS and dispersion tests for Bacteroides functions. We
tested whether there were differences in the functions of all BacteroidesMAGs in the
p_patient versus n_patient groups, whether there were significant differences in the
functional potential of species, and whether patients harbor Bacteroides with a distinct
functional potential.
b Comparison between samples from pouchitis and nonpouchitis patients.
c Comparison of functional potential based on RAST species assignment.
d Comparison among patients.
e P value for the test of equal variation (dispersion) among groups (null hypothesis of
no difference).
TABLE 1 ADONIS and dispersion tests for differences in community composition
Comparison
MED GAST MG-RAST
R2 P value Dispd R2 P value Disp R2 P value Disp
Patient groupa 0.02 0.001 0.105 0.03 0.001 0.091 0.01 0.169 0.159
Conditionb 0.02 0.001 0.762 0.03 0.001 0.327 0.03 0.037 0.12
Patientc 0.49 0.001 0.001 0.43 0.001 0.001 0.30 0.001 0.001
a Comparison between samples from pouchitis and nonpouchitis patients.
b Comparison among samples taken from a pouch after antibiotic treatment, during inflammation, uninflamed pouchitis patient, and non-pouchitis patients.
c Comparison among patients.
d P value for the test of equal variation (dispersion) among groups (null hypothesis of no difference).
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within rapidly evolving chromosomal regions. We initially fo-
cused our attention on gene clusters necessary for capsular
polysaccharide (CPS) production. These functionally related
but compositionally distinct gene clusters can occur multiple
times within highly variable regions of the Bacteroides genome
(9). The composition of genes necessary for CPS biosynthesis,
including transcriptional regulatory elements (UpxY and
UpxZ), coding regions for glycosyltransferase genes, UDP-N-
acetylglucosamine 2-epimerase (EC 5.1.3.14), and glucosamine-
6-phosphate deaminase (EC 3.5.99.6) did not significantly differ
among patients or between pouchitis and nonpouchitis patients.
The correlation between the assemblage of CPS loci and RAST
species assignment was high (R2  0.44) and significant (P 
0.001). The B. fragilis, B. thetaiotaomicron, B. ovatus, and B. ster-
corisMAGs contain a mean of 64, 52, 45, and 38 CPS biosynthetic
cluster genes, respectively, while B. vulgatus contained a mean of
35 such genes per genome. Each of the B. fragilis genomes con-
tained multiple copies of the upxY and upxZ loci responsible for
transcriptional regulation of CPS. The number of upxZ regulatory
loci in B. fragilis MAGs ranged from two to eight distinct copies.
The MAG that contained only two regulatory element coding re-
gions assembled to ~50%of the length of otherB. fragilis genomes
and was isolated from an n_patient. The MAGs of B. thetaiotao-
micron but not B. ovatus also contained these regulatory genes.
The composition of the genes downstream of the regulatory ele-
ments in B. fragilis varied in gene number and content within and
between each of the genomes and included several genes that are
known to be virulent within other genera (see Fig. S4 in the sup-
plementalmaterial).Wedetectedgenesnecessary tometabolize sialic
acids, including N-acetylneuraminic acid (Neu5Ac) including neuB
(N-acetylneuraminate synthase [EC 2.5.1.56]) andmnaA (UDP-N-
acetylglucosamine2-epimerase [EC5.1.3.14]) in eachof theB. fragilis
MAGs isolated from pouchitis patients. Virulence factors in the Bac-
teroidesMAGs recovered at high abundance from inflamed samples
included colicin V production (colicin V [PF02674]), bile hydrolysis
(choloylglycinehydrolase [EC3.5.1.24]), resistance tomercury (mer-
curic ion reductase [EC 1.16.1.1]), resistance to copper (CutC
[PF03932]), and amycobacterium-like virulence operonpossibly in-
volved in quinolinate biosynthesis (quinolinate synthetase [EC
2.5.1.72], L-aspartate oxidase [EC 1.4.3.16], and quinolinate phos-
phoribosyltransferase [EC 2.3.2.19]). None of the MAGs contained
contigswith sequence similarity to theBacteroides fragilis toxin (BFT)
according to an hidden Markov model (HMM) search for the
N-terminal domain of fragilysin (PF16376).
Bacteroides cultivar genomes. Cultivation efforts yielded 14
Bacteroides isolates from I,W, andN samples from four p_patients
and two n_patients. The isolation of cultivars and determination
of their genome sequence confirmed draft genome assemblies
from the shotgunmetagenome and described differences between
related genomes. In this study, each of the 14 Bacteroides cultivar
shotgun genomic data sets assembled into draft genomes with a
minimum length of 4.4Mbp and containedmore than 4,217 cod-
ing sequences and 354 to 356RAST (21) subsystems. The genomes
of cultivars isolated from patients p-212, p-214, p-207, p-215, and
n-216 represent distinct bacterial isolates that share strong homol-
ogy with B. fragilis in the RAST database. The p-219 cultivar ge-
nome resolves to B. ovatus. Reciprocal mapping of short reads
from each B. fragilis cultivar assembly to all other assembled cul-
tivar genome sequences in this study demonstrates that each short
read is derived from a distinct but very closely related B. fragilis
MAGwith the same oligotype. In agreement with observations of
only one B. fragilis MAG for pooled longitudinal samples for a
given patient, each sequenced B. fragilis cultivar genome occurred
in only a single patient.MAUVEalignment (22) of the cultivar and
corresponding MAG contained an average of 94% shared nucle-
otide identity, and the correlation between the relative abundance
of metagenomic short reads recruited by the MAG and cultivar
was high and significant (R2  0.996; P value of 0.0001). Un-
aligned regions of the cultivar genome contained 45 to 332 genes
(1 to 7% of the genome) that weremissing inMAGs isolated from
the same patient. Genes that define transposons, ribosomal pro-
teins, and hypothetical proteins accounted for 69 to 97% of these
coding region differences.
Metagenomic and reciprocal cultivar mapping. Mapping
short reads from each metagenomic data set to the assembled
Bacteroides cultivar genomes enables assessments of genome cov-
erage (estimated by read recruitment) and detection of potential
genome insertions, deletions, and successions (by new popula-
tions) in longitudinal studies of each patient. The short metag-
enome reads for longitudinal luminal samples from patient 204
cover 100% of the p-204 B. fragilis cultivar genome sequence (see
Fig. S5 in the supplemental material). In contrast, patterns of read
recruitment to the p-214 cultivar genome differed for short met-
TABLE 3 ANOVA of Bacteroides relative abundancea
Comparison
GAST MG-RAST MAGs
Diff P value Diff P value Diff P value
I vs A 27.88 0.17 26.51 0.19 18.86 0.07
N vs A 3.64 0.99 5.25 0.97 4.43 0.91
W vs A 2.09 1.00 2.64 1.00 5.25 0.86
N vs I 24.24 0.06 21.26 0.08 23.29 0.00
W vs I 29.97 0.02 29.15 0.01 13.61 0.05
W vs N 5.73 0.80 7.89 0.63 9.68 0.05
a The results of the ANOVA and Tukey’s HSD test among inflamed (I), antibiotic (A),
without pouchitis (W), and n_patient (N) samples are summarized for three different
estimates of Bacteroides relative abundance (GAST, MG-RAST, and MAGs). The
ANOVA and Tukey’s HSD test are also reported for differences in the percentage of
metagenomic read recruitment to three Bacteroide fragilis cultivars isolated from two
pouchitis patients (p-207 and p-214) and one nonpouchitis patient (n-216). The groups
include metagenomic samples from the HMPDACC and I, A, W, and N samples. Diff
indicates the difference in percent relative abundance between the two groups being
compared. The P values of the ANOVA for the three estimates of abundance are as
follows: P 0.281 for GAST, P 0.017 for MG-RAST, and P 0.001 for MAGS. The
P values for the ANOVA of B. fragilis cultivar relative abundance were all0.001.
TABLE 4 ANOVA of B. fragilis read recruitmenta
Comparison
p-214 p-207 n-216
Diff P value Diff P value Diff P value
A vs HMPDACC 3.89 0.75 2.98 0.83 3.00 0.83
I vs HMPDACC 12.88 0.00 11.35 0.00 11.36 0.00
N vs HMPDACC 1.52 0.86 1.88 0.63 1.85 0.66
W vs HMPDACC 3.09 0.27 3.36 0.10 3.09 0.16
I vs A 8.99 0.14 8.37 0.10 8.36 0.11
N vs A 2.37 0.96 1.10 1.00 1.16 1.00
W vs A 0.80 1.00 0.38 1.00 0.08 1.00
N vs I 11.37 0.00 9.47 0.00 9.52 0.00
W vs I 9.80 0.00 7.99 0.01 8.27 0.00
W vs N 1.57 0.93 1.48 0.91 1.24 0.95
a See Table 3 footnote for details.
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agenomic sequences for longitudinal luminal samples collected
from the nonpouchitis patient n-212 and from pouchitis patients
p-204 and p-207 (Fig. 4). These data indicate that each patient
harbors a unique B. fragilis that remains stable over time. Many
regions from different patient metagenome samples that display
low or no read coverage when mapped to the p-214 genome en-
code proteins that function in CPS biosynthesis, including CpsM,
WcbM, and NeuB, while other examples indicate a clustering of
genes that likely play a role in transposition. Read mapping to the
p-214 cultivar also revealed differences between closely related
B. fragilis in the luminal versus mucosal samples. The high-
coverage regions represent conserved genetic elements shared be-
FIG 2 (A) Cluster dendrogram and heat map for the 20 most abundant oligotypes. Clustering employed average linkage of a Bray-Curtis dissimilarity matrix.
The labels for terminal branches show the patient number first (preceded by “p” or “n” indicating whether the patient eventually develops pouchitis elsewhere)
and then the number of days after initialization of the pouch; the colors of the terminal branches indicate the condition of the pouch at the time of sampling. The
heatmap represents scaled value for relative abundance of each oligotype per sample. The labels to the left of the heatmap indicate the bestmatch of the oligotype
sequence in the NCBI RefSeq RNA database followed by the unique oligotype identifier (ID). Longitudinal patterns of nonpouchitis (B) and pouchitis (C)
patients are displayed as bar plots. The patient ID is shown above each individual bar plot. The color of the bar corresponds with the oligotype ID of the heatmap.
The condition of the pouch and the number of days elapsed since pouch activation are displayed below each bar plot.
FIG 3 Bar plots show the temporal change in percent abundance of B. fragilis, B. vulgatus, B. ovatus, and B. thetaiotaomicronMAGs recovered from four patients
that developed pouchitis. The letters “a” and “b” in B. theta-a and B. theta-b denote two different MAGs that match B. thetaiotaomicron. The condition of the
pouch during each sampling is indicated by the color of the circle below each bar. EachMAG derived from the sample is displayed in chronological order as the
number of days following pouch activation. The relative abundance of each B. fragilis cultivar isolated from patients p204, p207, and p214 is displayed as a black
dot within the plot.
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tween B. fragilis genomes from the lumen and mucosa, whereas
the low-coverage regions represent putative differences between
genomes of the dominant B. fragilis populations of the lumen and
mucosa (Fig. 4). Failure to map reads to the cultivar genome se-
quence provides compelling evidence thatB. fragilis in the luminal
samples of patient p-214 differs not only from the B. fragilis in the
mucosal sample of patient p-214 but also differs in the same re-
gions from B. fragilis in the other pouchitis and nonpouchitis pa-
tients in this study. This variability in B. fragilis genomes also
appears in mapping experiments where the p-214 B. fragilis culti-
var genome recruited very few reads frommetagenomes that rep-
resent 154 healthy samples in the Human Microbiome Project
Data Analysis and Coordination Center (http://hmpdacc.org)
(Table 4; see also Fig. S6 at doi:10.6084/m9.figshare.3851481). The
mean relative abundance of B. fragilis in the HumanMicrobiome
Project (HMP) samples was 1.5% with a maximum of 19.7%,
which compares to an average of 5.8% with a maximum of 79.5%
in this study. Several regions of the genome receiving significant
coverage contain several conjugative transposons, antibiotic resis-
tance genes, and toxin-antitoxin genes (Table S5; see also Fig. S6 at
doi:10.6084/m9.figshare.3851481).
DISCUSSION
Close examination of severalB. fragilis cultivars isolated from lon-
gitudinal luminal samples combined with metagenomic read
mapping demonstrated that each patient harbored a distinct
B. fragilis population. These potential pathobionts were present
early after the creation of the pouch and persisted for at least
2 years, remaining at relatively high abundance during periods of
health, inflammation, and postantibiotic treatment. Comparisons
of luminal and mucosal samples from inflamed visits of the same
patient detected two distinct B. fragilis populations, one of which
could be detected only in mucosal samples. Comparisons of ge-
nomes from these organisms revealed that their differences prin-
cipally occurred within multiple capsular polysaccharide biosyn-
thesis loci that contribute to microcapsule production and
typically contain transcriptional regulatory elements (UpxY and
UpxZ), coding regions for glycosyltransferase genes, UDP-N-
acetylglucosamine 2-epimerase (EC 5.1.3.14), and glucosamine-
6-phosphate deaminase (EC 3.5.99.6). While Bacteroides organ-
isms are abundant members of the human intestinal tract, the
relatively abundant species during inflammation in this study
(B. fragilis, B. ovatus, B. vulgatus, and B. thetaiotaomicron) also
commonly occur in association with anaerobic infection and IBD
(23–25).
These Bacteroides represent known opportunistic pathogens
that can reach relative abundance of 80% in IBD patients with
cell numbers exceeding 109 cell/ml at the mucosal layer (25, 26).
The ability of Bacteroides to maintain high abundance during
pouch inflammation and normal epithelial function in the pouch
likely reflects their ability to activate, suppress, or evade an overly
active immune response during W, I, and A sampling visits, re-
spectively. To maintain the abundance patterns observed in this
study, members of the genusmust exploit a mechanism to survive
within each of these unique host environments. Several Bacte-
roides species (B. thetaiotaomicron,B. ovatus,B. fragilis, andB. vul-
gatus) have evolved multiple distinct capsular polysaccharides
through close interaction with host cells and other microbes
within the human intestinal tract.Bacteroides have evolved diverse
capsules that include both lipopolysaccharide and polysaccharide
(25). B. fragilis in this study contains at least eight unique CPS
biosynthesis loci that correspond to zwitterionic polysaccharide A
to polysaccharide H (PSA-PSH), which serve an essential role in
the growth, virulence, and adaptation to variable conditions (27).
The inversion of the promoter region regulates each polysaccha-
ride loci (28), but the UpxY and UpxZ proteins dynamically con-
trol expression (29). The expression of a single CPS operon and
location of its polysaccharide product on the surface in any given
cell lead to a population of antigenically diverse cells (30). This
FIG 4 Readmapping to the p-214 B. fragilis genome cultivar isolated during inflammation. The top green histogram shows the percent GC for 2-kbp segments
over 2.5 Mbp of the 5-Mbp draft genome from the B. fragilis cultivar isolated from the inflamed pouch of patient 214. The black histograms in the middle of the
figure represent mean coverage over 2-kbp genomic segments of short metagenomic reads (luminal or mucosal samples collected during inflammation from
patients p-204, p-207, p-214, and from the lumen of the nonpouchitis patient n-212) thatmapped 100%over their length with 97% identity to the p-214 cultivar
genome. Black bars on the purple background at the bottom of the figure display the positions of four genes [cpsM(V), wcbM, neuB, and upxZ] within capsular
polysaccharide biosynthesis (CPS) loci highlighted in yellow. Two regions highlighted in red represent mobile elements within the genome.
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population-level variability facilitates the survival of B. fragilis in
many environments and its ability to maintain significant relative
abundance without causing inflammation. Although the flanking
regions of the PSA-PSH are largely conserved, our mapping re-
sults indicate little to no homology between the PSA-PSH con-
tained in the well-characterized B. fragilis NCTC 9343 or among
each of the three cultivars identified in this study. These results
agree with other characterizations of B. fragilis CPS diversity (9).
Figure 4 reveals that the percent GC content of CPS loci differs
from the surrounding genome, consistent with recent transfer
events and/or recombination within the genome (31, 32).
Some of the CPS loci in BacteroidesMAGs contain genes (e.g.,
neuB, wcbM, and cpsM) that define virulence factors in other
pathogens. For example, the protein product of neuB catalyzes the
final step in the biosynthesis of the sialic acid Neu5Ac (33). The
potential decoration of CPS with sialic acids in Bacteroides culti-
vars from p_patients resembles mechanisms for avoiding or caus-
ing host innate immune response in other virulent organisms, e.g.,
Campylobacter jejuni, Escherichia coli, Neisseria meningitidis, and
Streptococcus suis (34). Several B. fragilis CPS loci in this study
contain genes encoding other elements that also occur within the
capsules of known virulent genomes, including cpsM from the
capsule of Streptococcus pneumoniae and Burkholderia pseudomal-
lei wcbM (35), which shares strong homology with hddC from
C. jejuni (36). The effect of wcbM, cpsM, and neuB in B. fragilis on
virulence remains unclear, but their presence within the genome
of otherBacteroides in this study suggests that theymay contribute
to the cause and/or elevation of a host immune response.
Previous reports have reported horizontal gene transfer be-
tween Bacteroides through pairwise comparison of genome se-
quences from isolates (37, 38). Comparisons of the MAGs and
cultivar genomes in this study provide suggestive evidence of gene
transfer between Bacteroides. For example, both a B. fragilisMAG
and the same genome from a cultivar draft genome from p-207
shared nearly 100% sequence identity with several genomic re-
gions of a MAG for B. vulgatus. The shared sequences spanned
coding regions for several outermembrane receptors, site-specific
recombinase, and integrative conjugative elements (ICEs) con-
taining tetracycline resistance genes. The presence of these genes
within independent blooms of two different species during in-
flammation suggests that they provide an adaptive advantage. We
also detected genes shared among some Bacteroides from all sam-
ple types formultiple patients, including ICEs, membrane-related
proteins, transcriptional regulatory genes, mobile element pro-
teins, outer membrane receptor proteins, and multidrug resis-
tance genes that confer increased fitness to Bacteroides. ICEs in
particular can be modified by transposons, resulting in the inser-
tion of genes from the recipient genome. This process can yield a
customized ICE that benefits subsequent Bacteroides colonization
of the gut (37). They exhibited high copy numbers (10 copies) in
relation to the surrounding genome of conjugative transposons
(CTn) and related genes common to CTn-like ICEs. The high
copy numbers indicate that these elements excise from the ge-
nome and replicate prior to moving to a recipient genome within
the pouch, consistent with previous work (39). Because transfer
events increase within inflamed environments, movement of
these genes in the pouch environment may be elevated among
Bacteroides and has the potential to transfer virulence genes from
the CPS of B. fragilis to other species and possibly across genera.
While antibiotics seemed to reduce the severity of disease (1, 2,
8), the abundance of Bacteroides did not significantly decrease,
and in three patients, the same Bacteroides returned 1month after
antibiotic treatment was completed. The reestablishment of Bac-
teroides following antibiotic treatment could reflect the presence
of multiple antibiotic resistance genes (40), which spread by con-
jugation and mobilization (34). Alternatively, the same Bacte-
roidesmight reestablish from external sources or from survivors of
the original antibiotic treatment. Although B. fragilis was unde-
tected following antibiotic treatment in p-207, a previously unde-
tected B. vulgatus became dominant during refractory inflamma-
tion with functional similarity to a B. vulgatus from patient p-208
and contained ICEs carrying genes necessary for tetracycline and
clindamycin resistance. Ciprofloxacin was used to treat pouchitis
in this study, and it is unknownwhether tetracycline or clindamy-
cin genes would confer resistance to this antibiotic.
The high coverage of marker gene analysis contributes to re-
duced statistical variabilitywhen profilingmicrobial communities
and enables the detection of rare taxa. Yet, the reliance upon a
single locus constrains the level of information for resolving dif-
ferences between closely related taxa.MED’s ability to resolve am-
plicon sequences into oligotypes that differ by a single nucleotide
(11) offers increased resolution relative to taxonomy and cluster-
ing techniques (41, 42), but neither MED nor the MG-RAST an-
notation of short metagenomic reads detected community shifts
revealed through comparisons of theMAGs. Despite having iden-
tical oligotypes and essentially identical functional annotations,
read mapping to cultivar draft genomes described differences be-
tween B. fragilis populations from different patients and between
luminal samples (M sample type) versus mucosal samples (GG
sample type) taken during that same inflammation visit. When
combined with longitudinal sampling of a patient, it became pos-
sible to track temporal changes in the abundance of closely related
but distinctBacteroidespopulations. AbundantBacteroides species
during inflammation were limited to B. ovatus, B. vulgatus, and
B. fragilis. Each of these Bacteroides genomes was 100% covered
over the length of all contigs at least once prior to inflammation.
These mapping results provide evidence for the presence of those
genomes in the patients’microbiomes prior to the development of
mucosal inflammation. In the case of p-214, the B. fragilis genome
appeared at least 1 year before inflammation, suggesting that in-
flammation results from a well-established but low-abundance
microbe. Read mapping from individual patient visits revealed
significant variation in response to antibiotics among Bacteroides
genomes. Several of the Bacteroides reached 10% relative abun-
dance following antibiotic treatment. In other patients, readmap-
ping did not detect the abundant Bacteroides after antibiotic treat-
ment. In the case of p-207, read mapping demonstrated that after
antibiotic treatment, B. vulgatus replaced the B. fragilis that dom-
inated during inflammation. B. vulgatus represented 23% of the
p-207 microbiome at a second inflammation visit.
Large-scale 16S rRNA surveys that have included hundreds of
IBD patients and healthy patient controls have contributed im-
portant information about dysbiosis variability but have not yet
identified at the genome level specific microbes that could direct
diagnosis or treatment of the disease. Although the number of
samples in this study is small compared to other studies (8, 43, 44),
the longitudinal sampling and clinical data paired with cultiva-
tion, shotgun metagenomic assemblies and 16S amplicon se-
quencing provide unique insights intomicrobial influences on the
development and course of pouchitis. We found a significant dif-
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ference in the overall community structure between the p_pa-
tients and n_patients; however, 3% differences in overall commu-
nity variation did not provide a useful clinical predictor of
inflammation. The relative abundance of Bacteroides increased
significantly during inflammation, but differences in its relative
abundance in p-patients versus n-patients were not significant.
The absence of data related to the state of the immune system and
other confounding factors may have compromised larger studies
where Bacteroides either decreased or weakly correlated with IBD
(43, 44). The lack of significant decreases in the relative abundance
of Bacteroides in the antibiotic-treated group highlights the ability
of Bacteroides to resist certain antibiotics (40, 45). The level of
interpersonal variation in overall community structure and the
diversity of Bacteroides are also important observations. The Bac-
teroides oligotypes were largely stable for a particular individual
and occurred acrossmultiple individuals, suggesting that the same
B. fragilis occurred in multiple patients, yet the B. fragilis MAGs
that correlate with those operational taxonomic units differed sig-
nificantly from each other at the nucleotide and functional levels.
Similar results for B. vulgatus provide further evidence for the lack
of sensitivity of 16S rRNA surveys to identify the particularmicro-
bial organisms that may be related to the disease.
Despite the abundance of Bacteroides and the presence of
known virulence genes, low-abundance members of the commu-
nity might elicit an inflammatory or synergistic interaction be-
tween multiple microbes and drive inflammation (12). Two un-
related taxa that were dominant during this study, Cetobacterium
somerae and Clostridium perfringens (44, 45), each might contain
genes that contribute to evading an immune response and/or elic-
iting an abnormal immune response. Different genera and/or
variants within the samemicrobial species likely contribute to the
etiology of IBD. Within closely related Bacteroides, the patient-
specific occurrence of dissimilar genome elements that define
functionally related gene clusters have the potential to drive mi-
crobial community dynamics and inflammation.
Complex host-microbe relationships leading to pouchitis vary
for individual patients. The biological variation may explain why
it has been so difficult to find a consistent pathogen in IBD using
conventional tools and cross-sectional study designs. Our results
underscore the importance of performing prospective studies
with highly curated clinical metadata and the application of mul-
tiple tools, including high-resolution genomics. The identifica-
tion of five potentially virulent Bacteroides spp. provides specific
targets for understanding the underlying mechanisms that lead to
refractory pouchitis and potentially IBD.While these conclusions
rely principally on abundance patterns from a small group of sam-
ples, the known virulence, unique capsule, and correlation with
disease index strongly support a role for these species as potential
causative agents of disease.
MATERIALS AND METHODS
Patient clinical history. Twenty-two patients recruited at the University
of ChicagoMedical Center had a previously confirmed diagnosis of ulcer-
ative colitis (UC) and underwent total proctocolectomy with ileal pouch
anal anastomosis (IPAA) as standard of care. Each patient underwent
endoscopic evaluation of the ileal pouch (pouchoscopy) for collection of
luminal contents and mucosal brushings in the ileal pouch. Patients were
sampled without bowel lavage or preparation 2 weeks, 4 weeks, 8 weeks,
and then every 4 months after pouch functionalization for a period of
2 years.
Marker gene analysis of pouchitis and nonpouchitis patients. The
marker gene analyses sequenced the v4v5 regions of bacterial 16S rRNA
coding regions according to themethods described in reference 46 for eachof
the 97 samples. A modification of Eren et al. (47) removed low-quality se-
quences, andGAST (16) assigned taxonomy prior to uploading sequences to
the Visualization and Analysis ofMicrobial Population Structures (VAMPS)
website (https://vamps.mbl.edu). Minimum entropy decomposition
(MED) identified high-resolution oligotypes (17, 18).
Bacteroides cultivar isolation. From four p_patients (p-207, p-214,
p-215, and p-219) and two n_patients (n-216 and n-212), we isolated 14
Bacteroides cultivars frommucosal (GG sample type) and luminal samples
(M sample type) from patients at visits without inflammation (W visits)
or with inflammation (I) or visits of patients whose surgically created
pouches never became inflamed throughout the duration of the study (N
visits). Aliquots (50 l) of patient samples (luminal aspirate or mucosal
samples, stored at 80°C) were streaked onto Bacteroides bile esculin
(BBE) agar and incubated at 37°C, anaerobically, for 72 h. Single colonies
substreaked at least twice onto BBE provided an inoculum for overnight
anaerobic incubation at 37°C in 10 ml of supplemented brain heart infu-
sion broth. DNA extraction from overnight cultures collected by centrif-
ugation (5,800 g, 10min, 4°C) followed theDNeasy blood and tissue kit
(Qiagen) manufacturer’s instructions for Gram-negative bacteria. Capil-
lary sequencing of PCR amplicons using the universal primers 27F (F
stands for forward) and 1525R (R stands for reverse) (48) confirmed the
taxonomic affinity of Bacteroides species cultivars.
Genomic and shotgunmetagenomic sequencing.ACovaris S220 ul-
trasonicator sheared 100 to 1,000 ng of DNA for each cultivar to 600 bp.
Library construction followed protocols for the NuGEN Ovation Ul-
tralowDNA library preparation or Illumina PCR-free library preparation
prior to sequencing on a HiSeq Illumina platform.Metagenomic libraries
were constructed for each of the 96 luminal (M) samples and three brush
(GG) samples from the mucosa. Following DNA extraction, a NEBNext
microbiome DNA enrichment kit reduced human genomic DNA contri-
bution from the brush samples. DNA (final concentration of 0.01 to
0.2 ng/l in 130 l of 1 Tris-EDTA [TE] buffer) was sheared to base
pairs. DNA shearing, end repair, adaptor ligation, and library amplifica-
tion followed the NuGEN protocol. Pippin prepPrep (Sage Biosciences)
selected for 170-bp inserts. Barcoded metagenomic libraries were se-
quenced on an Illumina platform to generate 97- to 113-bp paired-end
reads. Read coverage ranged from ~7 million to ~146 million with an
average of ~50 million reads/sample (see Table S3 in the supplemental
material).
A BLAST filtering pipeline (https://github.com/meren/BLAST-filtering-
pipeline) removed reads that matched the human reference genome at
minimum length and identity of 50% and 90%, respectively (http://
www.ncbi.nlm.nih.gov/assembly/2758/). MG-RAST (19) queried each
read against the COG (clusters of orthologous groups) database (49) and
M5nr database (50) and assigned a function/taxonomy if the query met
the following criteria: maximum E value of 1e-5, minimum identity of
60%, and minimum alignment length of 15 amino acids.
Shotgun metagenome assembly. Illumina-utils (https://github.com/
meren/illumina-utils) merged partially overlapping paired-end reads us-
ing “iu-merge-pairs” and retained joined sequences that displayed no
mismatches within the overlapping regions. The flag “--enforce-Q30-
check” eliminated paired-end reads if 66% of the bases in the first half of
each had an average Q-score of less than Q30 (51). After pooling the data
from samples taken throughout the longitudinal study of each patient,
CLCWorkbench v. 7.0.4 de novo assembled short reads into contigs with
aword size, bubble size, andminimumcontig length of 25, 165, and 2,000,
respectively. Bowtie 2 (52) mapped the reads from each patient sample to
the assembly generated for that patient. RAST (21) provided functional
annotation and taxonomy assignments of contigs in the assemblies.
Anvi’o (20) generated interactive trees that facilitate the assignment of
contigs to shotgun MAGs. The tetranucleotide frequency, congruence of
coverage at each time point, taxonomy,GC content, and percentage of the
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contig covered defined the initial placement of each contig into a MAG.
Anvi’o scanned all contigs for single-copy genes using HMMer v3.1b2
(53) and four single-copy gene collections (54–57) to estimate completion
and contamination for each MAG. We scanned all contigs in each MAG
for capsular polysaccharide (CPS) biosynthesis clusters (58) based upon
similarity to gene models for neuB (http://pfam.xfam.org/family/NeuB),
wcbM, (http://pfam.xfam.org/family/PF00483), capsular polysynthetase
(http://pfam.xfam.org/family/PF05704), and upxZ (http://pfam.xfam
.org/family/PF06603). Contigs were also scanned for Bacteroides fragilis
toxin (BFT) using an HMMmodel for the N-terminal domain of fragily-
sin (http://pfam.xfam.org/family/PF16376).
Cultivar genome assembly. After quality filtering, the CLC Work-
bench v. 7.0.4 de novo assembled short reads into contigs. Mapping shot-
gun metagenomic reads from a patient sample to each B. fragilis cultivar
genome assembly described the relative abundance of that cultivar in each
patient visit sample. Reciprocal mapping of reads across cultivar genomes
identified differences in gene content between the Bacteroides isolates,
including the presence/absence and occurrence of multicopy genes. Read
mapping shotgun metagenomic data sets from stool samples for 154
healthy humans against cultivar genomes from patients p-207, p-214, and
n-216 identified genomic regions shared among Bacteroides from healthy
patients in the HumanMicrobiome Project Data Analysis and Coordina-
tion Center (HMPDACC) (59, 60) and our cultivars. Bowtie 2 v2.0.5 (52)
mapped short reads to contigs for visualizing coverage using anvi’o (52).
The number of reads that mapped to the cultivar contigs divided by the
total number of reads in the data set described the relative abundance of
B. fragilis cultivars in each shotgun metagenomic data set. MAUVE
aligned MAG and cultivar DNA sequences to determine the shared per-
cent nucleotide identity.
Statistical analysis.ANOVA (analysis of variance) was used to test for
significant differences in mean Bacteroides abundance among samples
fromN,W, I, andA visits. Estimates ofBacteroides abundance fromGAST
taxonomy, MG-RAST short-read annotation, and read recruitment to
draft genomes served as input for the ANOVA. A posthoc Tukey’s HSD
(honestly significant difference) test identified groups with significantly
different means (61), and a Bartlett test determined whether the abun-
dance variance differed significantly among groups (62). ANOVA tested
for differences in the mean percent relative abundance of cultivar ge-
nomes from patient p-207, p-214, and n-216 in the 154 HMPDACC data
sets and in samples from N, W, I, and A visits.
A linear mixed-effects model identified microbial groups that showed
differences in abundance during inflammation. The model contained
fixed effects for inflammation and days elapsed after the return of fecal
flow into the pouch. Random effects of the model included patients and
patient groups (n_patients versus p_patients). Coefficients and 97.5%
confidence intervals for themodel were estimated using the lmer function
with restricted maximum likelihood (REML) in the R package “lme4”
(63). The P values for fixed-effect model coefficients were adjusted using
the Benjamin-Hochberg procedure to control the false-discovery rate
(FDR). The relative abundance of each genus and oligotype served as
input for the model.
Percent relative abundance matrices for GAST taxonomy, oligotypes,
MG-RAST functional annotation, and RAST functional annotation of
Bacteroides MAGs recovered from metagenomic samples provided input
for bar plots, heat maps, and hierarchical cluster analysis. Hierarchical
clustering for comparing microbiome composition employed the Ward
(64) method on a Bray-Curtis (65) dissimilarity matrix. ADONIS, a non-
parametric multivariate analysis of variance method tests for significant
differences in beta diversity between specified groups and a null distribu-
tion that we created through permutation of the beta diversity matrix.
ADONIS, a nonparametric multivariate analysis of variance method in
the VEGAN package (66), tested for significant clustering of patient,
pouch outcome (p_patients versus n_patients), and pouch condition (W,
I, N, and A visits) variables for the GAST, MED, and MG-RAST input
matrices generated with betadiver. ADONIS tested for significant cluster-
ing of the Bacteroides draft genome functional matrix for three variables:
RAST species assignment, patient identifier (ID), and pouch outcome
(p_patients versus n_patients). The betadisper function tested for differ-
ences in the homogeneity of group variances (67). R was used for all
statistical analysis and visualization (68).
Data availability. The metagenomic and cultivar sequences are avail-
able through the NCBI Sequence Read Archive dbGaP (accession
phs000262) and VAMPS hosts 16S sequences (https://vamps.mbl.edu)
under project names HMP_200, HMP_202, HMP_204, HMP_207,
HMP_208, HMP_209, HMP_210, HMP_211, HMP_ 212, HMP_213,
HMP_214, HMP_215, HMP_216, HMP_217, HMP_218, HMP_219,
HMP_423, HMP_427, HMP_500, HMP_502, and HMP_503.
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